Related Experiment Video
Updated: Jun 26, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Rheumatoid arthritis.
Lars Klareskog1, Anca Irinel Catrina, Stephen Paget
1Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Lancet (London, England)
|January 23, 2009
Summary
Innovative biological agents targeting the immune system have transformed rheumatoid arthritis (RA) treatment, improving patient outcomes. Further research into genetic and environmental factors may enable personalized treatments and disease prevention.
Area of Science:
- Immunology
- Rheumatology
- Molecular Pathogenesis
Background:
- Rheumatoid arthritis (RA) is a systemic, inflammatory, autoimmune disorder.
- Understanding molecular pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To highlight advancements in biological agents for rheumatoid arthritis.
- To discuss the role of environmental factors and genetic susceptibility in RA pathogenesis.
- To explore new therapeutic strategies for managing joint inflammation and destruction.
Main Methods:
- Review of molecular pathogenesis in rheumatoid arthritis.
- Analysis of environmental factor interactions with susceptibility genes.
- Longitudinal study of disease processes and molecular pathology of joint inflammation.
Main Results:
- Biological agents targeting specific immune pathways have significantly altered RA course and patient outcomes.
- New insights into gene-environment interactions illuminate pathogenesis in a major RA subset.
- Current therapeutic strategies, including early use of disease-modifying drugs, can halt most joint destruction but not all inflammation or comorbidities.
Conclusions:
- Enhanced understanding of RA pathogenesis has led to effective biological treatments.
- Identifying causes and pathogenesis of RA subsets is key to personalized medicine and potential prevention.
- Continued research promises further improvements in managing rheumatoid arthritis and its associated conditions.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...